I DO think it is a good idea to keep trying to move forward. The new anti-coagulation drugs really did need to be tested to see if they would work (IMHO).
here's the thing, they ARE tested before they go to trial. Often that testing reveals flaws but they "cook the data" to get it through to enable a public trial.
CryoLife in particular has more of this in their history than any other valve maker that I can think of.
To my mind (and I have friends who I went to Uni with who quit because of ethics) it takes a particular type of person to keep working in research in the face of "lets discount this data and apply for a trial".
To be clear its not every researcher, but we have reached that part of the curve when the amount of research to uncover a new drug makes the cost benefit pretty much an asymptote.
The low hanging fruit has been picked already.
Meanwhile warfarin has been in public circulation for some time:
Warfarin was formally approved for human use by the U.S. Food and Drug Administration (FDA) to treat blood clots in 1954. In 1955, warfarin's reputation as a safe and acceptable treatment was bolstered when President Dwight D. Eisenhower received warfarin following a massive and highly publicized heart attack.
(
wikipedia)
Since then we've (
in the face of fierce opposition from vested interests) introduced much better outcomes with self testing and self administration (
some pockets of financial resistance remain)